Seven-Day Vein-to-Vein Point-of-Care Manufactured CD19 CAR T Cells (GLPG5201) in Relapsed/Refractory CLL/SLL Including Richter's Transformation: Results from the Phase 1 Euplagia-1 TrialNatalia Tovar,Valentin Ortiz-Maldonado,Nuria Martinez-Cibrian,Sergi Betriu,Daniel Esteban,Ana Triguero,Nadia Verbruggen,Maike Spoon,Marte C. Liefaard,Margot Pont, Anna D.D. van MuydenBlood（2023）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
